Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes

NCT01654341 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 986

Last updated 2019-03-26

No results posted yet for this study

Summary

The MID-Frail STUDY project focuses on the use of interventions designed to improve functional status and enhance quality of life (rather than traditional treatments such as glucose- and blood pressure- lowering) by acting on the mechanisms involved in producing frailty and its progression to adverse outcomes.

Conditions

Interventions

BEHAVIORAL

Exercise, dietary and educational program

Sponsors & Collaborators

  • Cardiff University

    collaborator OTHER
  • Igen Biotech SL

    collaborator UNKNOWN
  • University Hospital, Bordeaux

    collaborator OTHER
  • Hexabio Sarl

    collaborator UNKNOWN
  • University of Campania Luigi Vanvitelli

    collaborator OTHER
  • University Hospital, Toulouse

    collaborator OTHER
  • University of Ulm

    collaborator OTHER
  • University Ghent

    collaborator OTHER
  • University of Castilla-La Mancha

    collaborator OTHER
  • Univerzita Karlova v Praze

    collaborator OTHER
  • Niche Science & Technology Ltd

    collaborator UNKNOWN
  • Catholic University of the Sacred Heart

    collaborator OTHER
  • Vrije Universiteit Brussel

    collaborator OTHER
  • Diabetes Frail Ltd

    collaborator OTHER
  • Hospital Universitario Getafe

    lead OTHER

Principal Investigators

  • Leocadio Rodríguez Mañas, MD · Hospital Universitario de Getafe

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654341 on ClinicalTrials.gov